跳至主要内容
临床试验/JPRN-UMIN000006971
JPRN-UMIN000006971已完成4 期

Ezetimibe clinical investigation for the regression of intracoronary plaque evaluated by angioscopy and ultrasound - eZetimibe clinical investigation for the regression of Intracoronary Plaque evaluated by ANGioscopy and Ultrasound(ZIPANGU study)

Japan Health Promotion Foundation0 个研究点目标入组 130 人开始时间: 2011年12月28日最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
130

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients have hypersensitivity to test medicines 2) triglyceride>=400mg/dL 3) Patients with severe liver/renal disease(AST and/or ALT is as thrice as standard value/ dialysis, serum creatinine>2.0mg/dL and/or CK>500IU/L) 4) HbA1c>=8% (JDS, >=8.4% in NGSP) or taking administration of insulin 5) Patients with ACS(AMI, unstable angina) histories within 3 months 6) Patients with secondary hyperlipidemia or drug induced hyperlipidemia 7) Patients diagnosed malignancy 8) Patients with familial hypercholesterolemia 9) Pregnant,breast-feeding, becoming pregnant 10) treatment with cyclosporine 11) inadequate to this study

研究者

发起方
Japan Health Promotion Foundation

相似试验